Pharmaceutical development of a parenteral formulation of conivaptan hydrochloride
K Ban, R Sonohara, M Yoshida, K Sako… - PDA Journal of …, 2013 - journal.pda.org
Conivaptan hydrochloride injection (Vaprisol®) was developed for the treatment of
hyponatremia. Because the drug is very slightly soluble in water, pH control and cosolvency …
hyponatremia. Because the drug is very slightly soluble in water, pH control and cosolvency …
[CITATION][C] Hydrogele auf der Basis von Hydroxyethylstärke als Drug-delivery-Systeme für die kontrollierte Freisetzung von Proteinen
K Scheibe - 2007 - Braunschweig, Techn. Univ., Diss …
[CITATION][C] The analysis of pharmaceutical substances and formulated products by vibrational spectroscopy
D Clark - Handbook of Vibrational Spectroscopy, 2006 - Wiley Online Library
The sections in this article are
[CITATION][C] The analysis of pharmaceutical substances and formulated products by vibrational spectroscopy
D Clark, A Pysik - Handbook of Vibrational …, 2002 - John Wiley & Sons Ltd, Chichester …